Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has submitted to BSE a compliance certificate under SEBI Regulation 74(5) for the quarter ended December 31, 2025. The certificate, issued by the company's Registrar and Transfer Agent, Aarthi Consultants Pvt Ltd, confirms that all share certificates received from depository participants for dematerialization during October–December 2025 were processed within the required 15-day timeline. The activities include mutilating and cancelling the physical certificates, substituting the depository's name as the registered owner, and ensuring the securities remain listed on the stock exchange. The letter was signed by the Company Secretary on January 16, 2026.
This is a routine quarterly regulatory filing with no impact on the company's financials, operations, or share price. It simply confirms procedural compliance in handling dematerialization requests.